<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="article-commentary" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">J Clin Invest</journal-id>
<journal-id journal-id-type="iso-abbrev">J. Clin. Invest</journal-id>
<journal-id journal-id-type="publisher-id">J Clin Invest</journal-id>
<journal-title-group>
<journal-title>The Journal of Clinical Investigation</journal-title>
</journal-title-group>
<issn pub-type="ppub">0021-9738</issn>
<issn pub-type="epub">1558-8238</issn>
<publisher>
<publisher-name>American Society for Clinical Investigation</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">29252213</article-id>
<article-id pub-id-type="pmc">5785255</article-id>
<article-id pub-id-type="publisher-id">98761</article-id>
<article-id pub-id-type="doi">10.1172/JCI98761</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Commentary</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Micro(glial)-managing executive function: white matter inflammation drives catatonia</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Pease-Raissi</surname>
<given-names>Sarah E.</given-names>
</name>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Chan</surname>
<given-names>Jonah R.</given-names>
</name>
</contrib>
</contrib-group>
<aff>Department of Neurology and UCSF Weill Institute for Neuroscience, UCSF, San Francisco, California, USA.</aff>
<author-notes>
<corresp>Address correspondence to: Sarah E. Pease-Raissi, University of California, San Francisco, Sandler Neurosciences Center, 675 Nelson Rising Lane, Room 260, Box 3206, San Francisco, California 94158, USA. Phone: 415.353.4390; Email: <email>sarah.raissi@ucsf.edu</email>.</corresp>
<fn fn-type="COI-statement">
<p><bold>Conflict of interest:</bold> J.R. Chan is cofounder of Inception 5 and a consultant for Inception Sciences. S.E. Pease-Raissi and J.R. Chan declare research support from Mead Johnson Nutrition.</p>
</fn>
</author-notes>
<pub-date date-type="pub" iso-8601-date="2017-12-18T16:00:00-0500" publication-format="electronic">
<day>18</day>
<month>12</month>
<year>2017</year>
</pub-date>
<pub-date date-type="pub" iso-8601-date="2018-02-01T16:00:00-0500" publication-format="print">
<day>1</day>
<month>2</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>1</day>
<month>2</month>
<year>2019</year>
</pub-date>
<!-- PMC Release delay is 12 months and
						0 days and was based on the <pub-date
						pub-type="ppub"/>. -->
<volume>128</volume>
<issue>2</issue>
<fpage>564</fpage>
<lpage>566</lpage>
<permissions>
<copyright-statement>Copyright © 2018, American Society for Clinical Investigation</copyright-statement>
<copyright-year>2018</copyright-year>
<copyright-holder>American Society for Clinical Investigation</copyright-holder>
</permissions>
<self-uri xlink:href="https://www.jci.org/articles/view/98761">This article is available online at https://www.jci.org/articles/view/98761</self-uri>
<abstract>
<p>White matter abnormalities are prevalent in neuropsychiatric disorders such as schizophrenia, but it is unclear whether these abnormalities represent a cause or consequence of these disorders. Reduced levels of the myelin protein 2′-3′-cyclic nucleotide 3′-phosphodiesterase (CNP) are associated with the schizophrenic symptom catatonia in both humans and mouse models. In this issue of the <italic>JCI</italic>, Janova et al. show that reduced CNP levels correlate with catatonia and white matter inflammation in human subjects. Furthermore, they demonstrate that microglial ablation prevents and alleviates catatonic signs in <italic>Cnp<sup>–/–</sup></italic> mice, indicating that microglial-mediated inflammation causes catatonia. Together, this study identifies a cellular mechanism by which subtle myelin abnormalities cause low-grade neuroinflammation and catatonic behavior.</p>
</abstract>
</article-meta>
</front>
</article>
</pmc-articleset>